Deferoxamine attenuates bone cancer pain via modulation of the RIG-I/CCL5 signaling pathway in rats
{{output}}
Bone cancer pain (BCP) severely compromises the quality of life, and its molecular mechanisms are not fully understood. Increasing evidence implicates spinal iron overload in pain-related neuroinflammation, with the chemokine CCL5 acting as a critical mediator... ...